Biotechnology double deals ... - Part 2

A string of US-listed biotechnology deals have been announced today.

They include: Boston Scientific's $3.7 billion acquisition of US-listed medical technology company Axonics and Merck's $680 million takeover of Harpoon Therapeutics.

Also, announced today was Johnson & Johnson's $2 billion acquisition of US-listed biopharmaceutical company Ambrx. Below is the link to that deal announcement:..


Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Monday, 8 January 2024, 1:00 pm

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation